DJIA 18,150.21 108.67 0.60%
NASDAQ 5,075.76 43.01 0.85%
S&P 500 2,116.55 12.35 0.59%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

130.82 2.95 (2.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $131.26 2.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $128.06
Previous Close $127.87
Daily Range $127.00 - $130.94
52-Week Range $51.93 - $132.99
Market Cap $11.0B
P/E Ratio -72.24
Dividend (Yield) $0.00 (0.0%)
Volume 168,069
Average Daily Volume 770,597
Current FY EPS -$2.96

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary Rss Feed

Alnylam Pharmaceuticals, Inc.'s Five-Year Plan

The biotech updated investors on its Alnylam 2020 plan during its first-quarter earnings announcement.

4 Big Biotech Companies to Sell Now

Alnylam Begins Phase 1 Clincial Trial For ALN-AS!

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog

After-Hours Movers Friday: Seventy Seven Energy, Kite Pharma

3 Health Care Stocks Nudging The Sector Higher

Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Ho

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Alibaba, CyberArk, Yelp, Rocket Fuel, Choice Hotels and More

Alynlam Pharmaceuticals (ALNY) Stock Falls in After-Hours Despite Better Than Expected Earnings

See More ALNY News...

ALNY's Top Competitors

ALNY $130.82 (2.31%)
Current stock: ALNY
AMGN $160.79 (1.12%)
Current stock: AMGN
GILD $112.36 (2.36%)
Current stock: GILD
BIIB $397.23 (1.11%)
Current stock: BIIB